Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

江苏宣泰药业有限公司🇨🇳 National Medical Products Administration

Approval Id: 8dBpLZoYu4m
Approval Number: 国药准字H20244865
Generic Name: 达格列净二甲双胍缓释片(Ⅲ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 达格列净5mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg。
Reg Date: 2024-09-10
Company Name: 江苏宣泰药业有限公司
Company Address: 南通市海门区滨江街道珠海路163号
Production Company Name: 江苏宣泰药业有限公司
Production Company Address: 南通市海门区滨江街道珠海路163号
Company Detail Path: /organization/jiang-su-xuan-tai-yao-ye-you-xian-gong-si
Production Company Detail Path: /organization/jiang-su-xuan-tai-yao-ye-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 10, 2024

Approval ID

8dBpLZoYu4m

Type

化学药品